Bright Lisa

• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Activity signal Earnings

Download results Settings

Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other

Notification date	Transaction date	Company	B/S Transaction type	Nb. shares Price Value	Number of shares	Price	Value
2026-03-04	2026-03-04	Ascendis Pharma A/S (ASND)	PrS Proposed sale	16,266 324.61 US$4,888,614	16,266	324.61	US$4,888,614
2026-03-02	2026-03-02	Ascendis Pharma A/S (ASND)	PrS Proposed sale	93,479 428.81 US$2,389,761	93,479	428.81	US$2,389,761
2025-08-13	2025-08-13	Ascendis Pharma A/S (ASND)	PrS Proposed sale	68,832 487.26 US$1,831,883	68,832	487.26	US$1,831,883
2025-03-04	2025-03-04	Ascendis Pharma A/S (ASND)	PrS Proposed sale	1,470 152.12 US$223,623	1,470	152.12	US$223,623
2024-03-05	2024-03-01	Ascendis Pharma A/S (ASND)	PrS Proposed sale	658 150.00 US$98,700	658	150.00	US$98,700
2024-02-29	2024-02-29	Ascendis Pharma A/S (ASND)	PrS Proposed sale	10,000 146.37 US$1,463,741	10,000	146.37	US$1,463,741
2019-10-31	2019-10-29	Intercept Pharmaceuticals Inc (ICPT)	PlS Planned sale	595 -3.1% 75.00 US$44,625	595 -3.1%	75.00	US$44,625
2019-07-03	2019-07-03	Intercept Pharmaceuticals Inc (ICPT)	PlS Planned sale	595 -2.9% 78.66 US$46,803	595 -2.9%	78.66	US$46,803
2019-04-03	2019-04-03	Intercept Pharmaceuticals Inc (ICPT)	PlS Planned sale	594 -2.8% 115.01 US$68,316	594 -2.8%	115.01	US$68,316
2019-01-09	2019-01-07	Intercept Pharmaceuticals Inc (ICPT)	PlS Planned sale	1,313 -6.5% 104.93 US$137,773	1,313 -6.5%	104.93	US$137,773